Journal of cancer & allied specialties最新文献

筛选
英文 中文
PRIMARY GASTROINTESTINAL STROMAL TUMOUR OF THE PROSTATE: A CASE REPORT OF A RARE TUMOUR 原发性胃肠道前列腺间质瘤:罕见肿瘤1例报告
Journal of cancer & allied specialties Pub Date : 2018-07-01 DOI: 10.37029/jcas.v4i2.161
M. A. I. Khalil, N. Khan, Azfar Ali, K. Mir
{"title":"PRIMARY GASTROINTESTINAL STROMAL TUMOUR OF THE PROSTATE: A CASE REPORT OF A RARE TUMOUR","authors":"M. A. I. Khalil, N. Khan, Azfar Ali, K. Mir","doi":"10.37029/jcas.v4i2.161","DOIUrl":"https://doi.org/10.37029/jcas.v4i2.161","url":null,"abstract":"A 70-year-old gentleman underwent prostatectomy for bladder outlet obstruction due to enlarged prostate and was found to have primary extragastrointestinal stromal tumour (EGIST). He has been started on imatinib therapy and is presently on follow-up. Prostatic EGIST should be one of the differential diagnoses in patients with enlarged prostate with normal prostate-specific antigen levels.Key words: Prostate, gastrointestinal stromal tumour, PSA  ","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80252971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
INHERITED GENETIC SUSCEPTIBILITY TO BREAST CANCER IN PAKISTAN 巴基斯坦乳腺癌的遗传易感性
Journal of cancer & allied specialties Pub Date : 2018-07-01 DOI: 10.37029/JCAS.V4I2.179
N. Muhammad, Ramsha Nawaz, F. Khan, H. Naeemi, M. U. Rashid
{"title":"INHERITED GENETIC SUSCEPTIBILITY TO BREAST CANCER IN PAKISTAN","authors":"N. Muhammad, Ramsha Nawaz, F. Khan, H. Naeemi, M. U. Rashid","doi":"10.37029/JCAS.V4I2.179","DOIUrl":"https://doi.org/10.37029/JCAS.V4I2.179","url":null,"abstract":"Breast cancer is a heterogeneous disease. Several genetic, environmental and lifestyle factors are involved in the aetiology of this disease. Genetic risk factors include alterations (mutations) in genes conferring risks to develop breast cancer. Depending on the associated lifetime risks of this malignancy, these genes are categorised into high-, moderate- and low-risk genes. Women carrying mutations in these genes are at an increased risk to develop breast cancer, ovarian cancer and several other malignancies. Breast carcinoma is the most reported malignancy in Pakistani females. Pakistan is a developing country with most of its population living in rural areas; hence, optimal healthcare facilities are inadequate for the early diagnosis and prevention of this disease. Hence, identification of individuals carrying mutations is clinically relevant as different strategies are available for the early detection, risk reduction and better management of this malignancy. This review summarises the findings of the major studies conducted in Pakistan to investigate the contribution of breast cancer predisposing genes. Furthermore, implications of the current studies and future research potentials are discussed.Key words: Breast cancer gene 1/2, breast cancer, checkpoint kinase 2, genetic susceptibility, Pakistan, RAD51C, tumour Protein p53, Vitamin D receptor","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"85 4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76195440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
THERANOSTICS- NEUROENDOCRINE TUMOURS 治疗学-神经内分泌肿瘤
Journal of cancer & allied specialties Pub Date : 2018-07-01 DOI: 10.37029/JCAS.V4I2.184
M. Younis, H. Bashir
{"title":"THERANOSTICS- NEUROENDOCRINE TUMOURS","authors":"M. Younis, H. Bashir","doi":"10.37029/JCAS.V4I2.184","DOIUrl":"https://doi.org/10.37029/JCAS.V4I2.184","url":null,"abstract":"<jats:p>-</jats:p>","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"89 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88123016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
AIR BRONCHOGRAM: THE UNTRUSTWORTHY SIGN 空气支气管图:不可靠的征兆
Journal of cancer & allied specialties Pub Date : 2018-07-01 DOI: 10.37029/JCAS.V4I2.180
Qurat-ul-Ain Shah, U. Masood, I. Niazi
{"title":"AIR BRONCHOGRAM: THE UNTRUSTWORTHY SIGN","authors":"Qurat-ul-Ain Shah, U. Masood, I. Niazi","doi":"10.37029/JCAS.V4I2.180","DOIUrl":"https://doi.org/10.37029/JCAS.V4I2.180","url":null,"abstract":"<jats:p>-</jats:p>","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74319387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
WHAT IS YOUR UNDERSTANDING OF SPINAL AND EPIDURAL ATTEMPT? 你对脊髓和硬膜外尝试有何理解?
Journal of cancer & allied specialties Pub Date : 2018-07-01 DOI: 10.37029/JCAS.V4I2.165
S. Yahya, A. Siddiqui
{"title":"WHAT IS YOUR UNDERSTANDING OF SPINAL AND EPIDURAL ATTEMPT?","authors":"S. Yahya, A. Siddiqui","doi":"10.37029/JCAS.V4I2.165","DOIUrl":"https://doi.org/10.37029/JCAS.V4I2.165","url":null,"abstract":"Background: The practice of spinal and epidural anaesthesia is well established the world over for a number of years. Sighting of spinal or epidural is conducted through various approaches at various levels of the spinal column. The number of attempts has its correlation with the post-spinal and epidural complications.Aim: The aim is to gather information about the understanding among the anaesthetists about the spinal/epidural attempt.Materials and Methods: A pro forma comprising of nine closed-loop questions was distributed to all the participants in the study, and they were requested to fill it anonymously and placed it back in a designated sealed box in anaesthetic  office.Results: A total of 20 pro formas were distributed, and all of them received back with 100% responses. All the participants accepted universally that attempting through another space makes it a second attempt. One of the respondents thought any backward movement means 2nd attempt, the majority of the responders thought it does not count as an attempt. Almost everyone considered another attempt if a needle is completely withdrawn and enters through another puncture site whether through a midline or paramedian approach.Conclusion: Most of the complications after neuraxial blockade are associated with the number of attempts alongside other factors that may play a role. A universal definition of a spinal and epidural attempt may decrease the complications associated with the central neuraxial blockade.Key words: Epidural, single attempt, spinal","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"22 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84489298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DOES PATHOLOGICAL T3A UPSTAGING OF CLINICAL T1 STAGE HAS ANY DIFFERENCE ON LONG-TERM SURVIVAL WHEN COMPARED TO PATHOLOGICAL AND CLINICAL T1 STAGE RENAL CELL CARCINOMA 与病理和临床t1期肾细胞癌相比,病理t3a期临床t1期对长期生存有任何差异吗
Journal of cancer & allied specialties Pub Date : 2018-07-01 DOI: 10.37029/jcas.v4i2.164
N. Khan, M. A. I. Khalil, Azfar Ali, A. Naeem, A. Rehman, K. Mir
{"title":"DOES PATHOLOGICAL T3A UPSTAGING OF CLINICAL T1 STAGE HAS ANY DIFFERENCE ON LONG-TERM SURVIVAL WHEN COMPARED TO PATHOLOGICAL AND CLINICAL T1 STAGE RENAL CELL CARCINOMA","authors":"N. Khan, M. A. I. Khalil, Azfar Ali, A. Naeem, A. Rehman, K. Mir","doi":"10.37029/jcas.v4i2.164","DOIUrl":"https://doi.org/10.37029/jcas.v4i2.164","url":null,"abstract":"Background: A high number of clinical T1 (cT1) stage renal cell carcinoma (RCC) is upstaged to pathological T3a (pT3a) stage on histopathological findings. Several study results show that there is no survival difference among those cT1 stage who are upstaged on histopathological findings to those who remain pT1 stage RCC.Objectives: The objectives of this study were to assess any survival difference for cT1 stage renal cell carcinoma (RCC) which is upstaged to pT3a stage as compared to those which remain pT1 stage RCC on histopathological findings.Materials and Methods: It was a retrospective cohort study looking at patient aged ≥18 years with cT1 RCC who underwent nephrectomy between January 2006 and December 2016. Patients were divided into two groups based on histopathological findings (pT1 vs. pT3a). Survival was analysed for the  two groups using Kaplan–Meier method, and the difference in survival was calculated using log-rank model.Results: The study included 187 patients. The mean age at presentation was 52.56 years, with 58.3% of the patients being male while 41.7% were female. The most common presentation was incidental diagnosis (50.3%). Overall5-year survival for cT1a and pT1a RCC was 68% while that for cT1a and pT3a RCC was 100%. There was no significant survival difference among the two groups (P = 0.316). The overall 5-year survival for cT1b and pT1b RCC was 81% while that for cT1b and pT3a was 65%. There was no significant survival difference among the two groups (P = 0.136).Conclusion: We found no survival difference in cT1 RCC who were upstaged to pT3a on histopathology as compared to cT1 RCC-staged pT1 on histopathology.Key words: Clinical T1 stage, pathological T3a stage, radical nephrectomy, renal cell carcinoma, survival","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"58 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72453203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信